Skip to main content

Table 4 Patient response to trial invitation

From: Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)

Patient sex

Total number of patients invited

Response to invitation

EOI

No

May in future

No response

Female

72,644

11,146 (15.3%)1

14,905 (20.5%)

1886 (2.6%)

44,707 (61.5%)

Male

116,231

27,625 (23.8%)2

19,274 (16.6%)

2918 (2.5%)

66,414 (57.1%)

  1. Numbers in brackets show the percentage of total invited 1females or 2males respectively for each response to invitation